Skip to main content
Log in

Extended-Release Tablets of Nitrofurantoin: An Old Antibiotic Carried in a New Formulation

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Nitrofurantoin is an old antibiotic currently prescribed to treat urinary tract infections. High dosing frequency causes fluctuations in the drug plasma concentration making less desirable prescription. This work was aimed to overcome these shortcomings by developing extended-release formulations. Tablets were prepared using nitrofurantoin and crosslinked poly(acrylic acid) and hydroxypropyl methylcellulose (HPMC) as hydrophilic polymer matrices. Modified tablets containing HPMC exhibited adequate swelling, erosion, and dissolution profiles and showed potential to decrease the frequency of administrations and reduce fluctuations in the drug plasma concentration. This would result in higher therapeutic effect and increases patient compliance by reducing adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. Urinary Tract Infection. Centers for Disease Control and Prevention [Internet]. [cited 2018 Oct 10]. Available from: https://www.cdc.gov/antibiotic-use/community/for-patients/common-illnesses/uti.html

  2. Medical Student Curriculum: Adult UTI [Internet]. 2020 [cited 2020 Aug 2]. Available from: https://www.auanet.org/education/auauniversity/for-medical-students/medical-students-curriculum/medical-student-curriculum/adult-uti

  3. World Health Organization. Urinary Tract Infections [Internet]. [cited 2018 Nov 9]. Available from: www.who.int/gpsc/informationcentre/cauda-utieccmid.pdf

  4. Foundation NK. Urinary Tract Infections [Internet]. [cited 2018 Dec 9]. Available from: https://www.kidney.org/sites/default/files/uti.pdf

  5. R. M. Klevens, J. R. Edwards, C. L. Richards Jr., et al., Estimating Health Care-Associated Infections and Deaths in U. S. Hospitals, 2002. Public Health Rep [Internet]. 2007; 122(April):160–166. Available from: http://www.cdc.gov/HAI/pdfs/hai/infectionsdeaths.pdf

  6. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion. Adult Treatment Recommendations. [Internet]. [cited 2018 Feb 10]. Available from: https://www.cdc.gov/antibiotic-use/community/for-hcp/outpatient-hcp/adult-treatment-rec.html

  7. A. E. Muller, E. M. Verhaegh, S. Harbarth, et al., Clin. Microbiol. Infect., 23(6), 355–362 (2017).

    Article  CAS  Google Scholar 

  8. B. G. Katzung and A. J. Trevor, Miscellaneous Antimicrobial Agents; Disinfectants, Antiseptics, and Sterilants, in: B. G. Katzung. Basic and Clinical Pharmacology, 14th edn, McGraw-Hill Education: New York, NY (2017).

  9. A. Burke and M. D. Cunha, Med. Clin. North Am., 90(6), 1089 – 1107 (2006).

    Article  Google Scholar 

  10. G. Vasvári, J. Kalmár, P. Veres, et al., Drug Discov. Today Technol., 27(xx), 71 – 80 (2018).

    Article  Google Scholar 

  11. A. Burke and M. D. Cunha, Urology, 32(1), 67 – 71 (1988).

    Article  Google Scholar 

  12. R. Gröning and G. Heun, Int. J. Pharm., 56(2), 111 – 116 (1989).

    Article  Google Scholar 

  13. W. D. Mason, J. D. Conklin, and F. J. Hailey, Int. J. Pharm., 36(2–3), 105 – 111 (1987).

    Article  CAS  Google Scholar 

  14. C. Maderuelo, A. Zarzuelo and J. M. Lanao, J. Control. Release, 154(1), 2 – 19 (2011).

    Article  CAS  Google Scholar 

  15. B. M. Gibaldi and S. Feldman, J. Pharm. Sci., 56(10), 1238 – 1242 (1967).

    Article  CAS  Google Scholar 

  16. Brasil. Ministério da Saúde-MS, Agência Nacional de Vigilância Sanitária – ANVISA. Farmacopeia Brasileira, 6a edição. [Internet]. 2019; 1. Available from: http://portal.anvisa.gov.br/

  17. A. P. Cruz, C. D. Bertol, H. K. Stulzer, et al., Pharm. Chem. J., 42(7), (2008).

    Article  Google Scholar 

  18. J. Siepmann and F. Siepmann, Int. J. Pharm., 364(2), 328 – 343 (2008).

    Article  CAS  Google Scholar 

  19. P. Costa and J. M. S. Lobo, Eur. J. Pharm. Sci., 13, 123 – 133 (2001).

    Article  CAS  Google Scholar 

  20. J. W. Moore and H. H. Flanner, Pharm. Technol., 20(6), 64 – 74 (1996).

    Google Scholar 

  21. FDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms [Internet]. Vol. 4, U. S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research. 1997 [cited 2017 Jun 8]. pp. 15 – 22. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm070237.pdf

  22. Brasil. Resolução RDC No. 31, de 11 de agosto de 2010 [Internet]. Agência Nacional de Vigilância Sanitária (Anvisa). 2010 [cited 2016 Jun 25]. Available from: http://portal.anvisa.gov.br/documents/33880/2568070/res0031_11_08_2010.pdf/5e157d15-d3d5-4bb9-98db-5667e4d9e0c8

  23. N. H. Anderson, M. Bauer, N. Boussac, et al., J. Pharm. Biomed. Anal., 17(4–5), 811 – 822 (1998).

    Article  CAS  Google Scholar 

  24. Brasil. Resolução Da Diretoria Colegiada - RDC No. 166, de 24 de julho de 2017 [Internet]. Ministério da Saúde – MS Agência Nacional de Vigilância Sanitária ANVISA. 2017 [cited 2017 Aug 2]. Available from: http://portal.anvisa.gov.br/documents/10181/2721567/RDC1662017COMP.pdf/d5fb92b3-6c6b-4130-8670-4e3263763401

  25. International Conference on Harmonization. Validation of Analytical Procedures: Text and Methodology Q2 (R1). ICH Steer Committee, Switz. 2005; 17.

  26. S. Dash, P. Murthy, L. Nath, and P. Chowdhury, Acta Pol. Pharm. Drug Res., 67(3), 217 – 223 (2010).

    CAS  Google Scholar 

  27. R. Manadas, M. E. Pina, and F. Veiga, Rev. Bras. Ciências Farm., 38(4) (2002).

Download references

Conflict of Interest

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charise Dallazem Bertol.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bertol, C.D., Schonhorst, É.M., Tristacci, N.D.B. et al. Extended-Release Tablets of Nitrofurantoin: An Old Antibiotic Carried in a New Formulation. Pharm Chem J 55, 808–813 (2021). https://doi.org/10.1007/s11094-021-02499-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-021-02499-6

Keywords

Navigation